Literature DB >> 18443635

Opioid complications and side effects.

Ramsin Benyamin1, Andrea M Trescot, Sukdeb Datta, Ricardo Buenaventura, Rajive Adlaka, Nalini Sehgal, Scott E Glaser, Ricardo Vallejo.   

Abstract

Medications which bind to opioid receptors are increasingly being prescribed for the treatment of multiple and diverse chronic painful conditions. Their use for acute pain or terminal pain is well accepted. Their role in the long-term treatment of chronic noncancer pain is, however, controversial for many reasons. One of the primary reasons is the well-known phenomenon of psychological addiction that can occur with the use of these medications. Abuse and diversion of these medications is a growing problem as the availability of these medications increases and this public health issue confounds their clinical utility. Also, the extent of their efficacy in the treatment of pain when utilized on a chronic basis has not been definitively proven. Lastly, the role of opioids in the treatment of chronic pain is also influenced by the fact that these potent analgesics are associated with a significant number of side effects and complications. It is these phenomena that are the focus of this review. Common side effects of opioid administration include sedation, dizziness, nausea, vomiting, constipation, physical dependence, tolerance, and respiratory depression. Physical dependence and addiction are clinical concerns that may prevent proper prescribing and in turn inadequate pain management. Less common side effects may include delayed gastric emptying, hyperalgesia, immunologic and hormonal dysfunction, muscle rigidity, and myoclonus. The most common side effects of opioid usage are constipation (which has a very high incidence) and nausea. These 2 side effects can be difficult to manage and frequently tolerance to them does not develop; this is especially true for constipation. They may be severe enough to require opioid discontinuation, and contribute to under-dosing and inadequate analgesia. Several clinical trials are underway to identify adjunct therapies that may mitigate these side effects. Switching opioids and/or routes of administration may also provide benefits for patients. Proper patient screening, education, and preemptive treatment of potential side effects may aid in maximizing effectiveness while reducing the severity of side effects and adverse events. Opioids can be considered broad spectrum analgesic agents, affecting a wide number of organ systems and influencing a large number of body functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443635

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  510 in total

1.  Spinal CX3CL1/CX3CR1 May Not Directly Participate in the Development of Morphine Tolerance in Rats.

Authors:  Yawen Peng; Genhua Guo; Bin Shu; Daiqiang Liu; Peng Su; Xuming Zhang; Feng Gao
Journal:  Neurochem Res       Date:  2017-08-03       Impact factor: 3.996

2.  Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.

Authors:  G Roussy; H Beaudry; M Lafrance; K Belleville; N Beaudet; K Wada; L Gendron; P Sarret
Journal:  Neuroscience       Date:  2010-08-18       Impact factor: 3.590

3.  New Perspectives in the Treatment of Opioid-Induced Respiratory Depression.

Authors:  Loretta Fala; John A Welz
Journal:  Am Health Drug Benefits       Date:  2015-10

Review 4.  Evolving paradigms in the treatment of opioid-induced bowel dysfunction.

Authors:  Jakob Lykke Poulsen; Christina Brock; Anne Estrup Olesen; Matias Nilsson; Asbjørn Mohr Drewes
Journal:  Therap Adv Gastroenterol       Date:  2015-11       Impact factor: 4.409

5.  Transversus abdominis block utilizing liposomal bupivacaine as a non-opioid analgesic for postoperative pain management.

Authors:  Thomas C Robertson; Kathryn Hall; Susan Bear; Kyle J Thompson; Timothy Kuwada; Keith S Gersin
Journal:  Surg Endosc       Date:  2018-11-02       Impact factor: 4.584

6.  Evaluation of opioid use among patients with back disorders and arthritis.

Authors:  Corey J Hayes; Nalin Payakachat; Chenghui Li
Journal:  Qual Life Res       Date:  2018-07-23       Impact factor: 4.147

Review 7.  Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain.

Authors:  Aswini Kumar Giri; Victor J Hruby
Journal:  Expert Opin Investig Drugs       Date:  2013-12-13       Impact factor: 6.206

8.  Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies.

Authors:  Dylan Zylla; Grant Steele; Alice Shapiro; Sara Richter; Pankaj Gupta
Journal:  Support Care Cancer       Date:  2018-02-02       Impact factor: 3.603

Review 9.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

10.  Opioid switching and variability in response in pain cancer patients.

Authors:  O Corli; A Roberto; N Corsi; F Galli; M Pizzuto
Journal:  Support Care Cancer       Date:  2018-10-24       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.